BM

Biju Moothedath

Director Director DIN 06501000
DIN 06501000 First appointment Apr 2013 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Apr 2013
Shareholding value Locked Premium profile

About Biju Moothedath

Biju Moothedath has 13 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 06501000
Primary Designation Director
First Appointment 04 Apr 2013
Oldest Company Age 13 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Apricot Pharmaceuticals Private Limited U24231KL2013PTC033713
Director 04 Apr 2013 2013 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Apricot Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Biju Moothedath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biju Moothedath

Biju Moothedath has 13 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Biju Moothedath is associated with 0 companies as Director.

Biju Moothedath has expertise in General Business.

Biju Moothedath has 13 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available